Product logins

Find logins to all Clarivate products below.


Breast Implants and Reconstructive Devices | Market Insights | Europe | 2022

The cancellation and postponement of elective procedures, including breast augmentations and reconstructions, due to the COVID-19 pandemic had a negative impact on the European market for breast implants and reconstructive devices in 2020. Recovery of the market will be affected by a number of factors, including the pace of vaccine distribution in the US, with postpandemic market growth supported by increasing aesthetic consciousness and the overall marketing efforts from the major players.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for breast implants and reconstructive devices in the US across an 11-year period.

Related Medtech Insights Reports

Report
Breast Implants and Reconstructive Devices – Market Insights – United States
The US breast implant and reconstructive device market is projected to advance steadily through 2035, supported by procedure demand but increasingly influenced by safety monitoring and FDA…
Report
Aortic Repair Devices – Market Insights – Europe
The European aortic stent graft market is the primary driver of growth in the aortic repair device market and will drive revenue expansion over the forecast period, supported by ongoing innovation…
Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for moderate growth over the forecast period, driven by increasing PCI volumes for complex CAD cases and the…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
The European EP mapping and ablation device market will grow moderately through 2035, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation…
Report
Cardiac Assist Devices – Market Insights – Europe
The European cardiac assist device market, although encumbered by recurring device recalls, will continue to grow rapidly due to new product development, expanded use across a broader patient…